Lefebvre, Carole Heitzmann, Patrick Pelletier, Sylvie Lecomte, Thierry Maakaroun, Abadallah
Published in
Bulletin du cancer
The COVID-19 pandemic disrupted the organisation of the healthcare system. Very little data is available regarding the impact of the COVID-19 pandemic on patients' perceptions of their healthcare pathway. The objective of this survey was to evaluate cancer patients' perceptions of the impact of the first COVID-19 lockdown on continuity of care, the...
Tran, Mélanie Brouard, Nora Hequet, Delphine Rouzier, Roman Donval, Lou
Published in
Bulletin du cancer
The COVID-19 pandemic had a profound impact on health-care systems and reduced access to care. This study assays the mid-term effects of the COVID-19 pandemic on breast cancer management over a 2-year-period in a single French Comprehensive Cancer Center. We performed, in a French comprehensive cancer center, an observational study including all pa...
Rousseau, Adrien Laune, Quentin Ollivier, Luc Naoun, Natacha Alexandre, Jérôme Giraud, Philippe Azria, David Delaye, Matthieu
Published in
Bulletin du Cancer
Contexte La pandémie de la COVID-19 a perturbé le fonctionnement des hôpitaux et de l’enseignement supérieur. Une précédente enquête a montré que la formation des internes avait été affectée lors de la première vague. Un an plus tard, nous souhaitons évaluer l’état des lieux de la formation des internes d’oncologie. Méthodes Il s’agit d’une enquête...
Despinasse, Marion Schohn, Anna Bimboes, Alexandre Trensz, Philippe Sirlin, Florian Chiappa, Pascale Frasie, Véronique
Published in
Bulletin du cancer
During the COVID-19 epidemic, the lockdown measures were associated with professional guidelines to care for patients. We noticed that the home nursing care of some patients monitored in supportive care wards were interrupted. The aim of this study is to determine the impact of lockdown on the home nursing care of patients monitored in supportive c...
Barrière, Jérôme Zalcman, Gérard Fignon, Laurent Peiffer-Smadja, Nathan Audigier-Valette, Clarisse Carles, Michel
Published in
Bulletin du cancer
Bay, Jacques Olivier Beguin, Yves Carpentier, Alexandre Dard, Céline Guillaume, Thierry Labussiere-Wallet, Hélène Lacassagne, Marie Noëlle Sauze, Séverine Yakoub-Agha, Ibrahim Chalandon, Yves
...
Published in
Bulletin du cancer
The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the dang...
Lucchi-Angellier, Elisabeth Mino, Jean-Christophe Burnod, Alexis Cottu, Paul Bozec, Laurence Escalup, Laurence Massing, Louise Papon, Marc Rizand, Philippe Fumoleau, Pierre
...
Published in
Bulletin du cancer
The Curie Institute exclusively cares for cancer patients, who were considered particularly "vulnerable" from the start of the SARS-CoV 2 pandemic. This pandemic, which took the medical world by surprise, suddenly required the Institute's hospital to undergo rapid and multimodal restructuring, while having an impact on everyone to varying degrees. ...
Barriere, Jérôme Bondouy, Michaël
Published in
Bulletin du cancer
Fenioux, Charlotte Allenbach, Yves Vozy, Aurore Salem, Joe-Élie Maalouf, Georgina Vieira, Matheus Le Joncour, Alexandre Benveniste, Olivier Saadoun, David Frère, Corinne
...
Published in
Bulletin du cancer
Patients with solid cancer or haematologic malignancies have been considered to be more susceptible to SARS-CoV-2 infection and to more often develop severe complications. We aimed to compare the differences in clinical features and outcomes of COVID-19 patients with and without cancer. This was a prospective observational cohort study of consecuti...
Tougeron, David Seitz-Polski, Barbara Hentzien, Maxime Bani-Sadr, Firouze Bourhis, Jean Ducreux, Michel Gaujoux, Sébastien Gorphe, Philippe Guiu, Boris Hardy-Bessard, Anne Claire
...
Published in
Bulletin du Cancer
La pandémie COVID-19 a un impact majeur à toutes les étapes de prise en charge des cancers. Le risque de décès de la COVID-19 chez les patients traités pour un cancer est élevé. La vaccination contre la COVID-19 représente une opportunité majeure pour réduire les risques de formes graves de la maladie et maintenir une filière de soins oncologiques ...
